MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
154 hedge funds and large institutions have $1.27B invested in Momenta Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
154
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
3.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
64
Reduced
47
Closed
16
Calls
$1.51M
Puts
$1.15M
Net Calls
+$358K
Net Calls Change
+$380K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.2M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$8.53M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$2.73M |
| 5 |
BlackRock
New York
|
+$2.28M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.74M |
| 2 |
Primecap Management
Pasadena,
California
|
-$4.36M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.17M |
| 4 |
Renaissance Technologies
New York
|
-$4.14M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$3.48M |
